About Memphasys
Memphasys is a company based in Homebush (Australia) founded in 2006.. Memphasys offers products and services including Felix™ System, Storage Medium, and Improved Medium. Memphasys operates in a competitive market with competitors including Cytoswim, Reproductive Solutions and ZyMot, among others.
- Headquarter Homebush, Australia
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Memphasys Limited.
-
Annual Revenue
$2.44 K (USD)-93.83as on Jun 30, 2025
-
Net Profit
$-3.26 M (USD)-11.25as on Jun 30, 2025
-
EBITDA
$-2.26 M (USD)24.38as on Jun 30, 2025
-
Latest Funding Round
$1.6 M (USD), Post-IPO
Aug 17, 2022
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Memphasys
Memphasys is a publicly listed company on the ASX with ticker symbol MEM in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Memphasys
Memphasys offers a comprehensive portfolio of products and services, including Felix™ System, Storage Medium, and Improved Medium. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device for separating sperm from semen in IVF procedures.
Medium for long-term ambient storage of human sperm.
Medium for sperm isolation, fertilization, and cryopreservation.
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Memphasys
- Total Funding Total Funding
- Total Rounds 1
- Last Round Post-IPO — $1.6M
-
First Round
First Round
(17 Aug 2022)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2022 | Amount | Post-IPO - Memphasys | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Memphasys
Memphasys has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Peters Investment Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global investment firm provides professional services for community improvement and international development.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Memphasys
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Memphasys
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Memphasys Comparisons
Competitors of Memphasys
Memphasys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytoswim, Reproductive Solutions and ZyMot, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Sperm selection tools for assisted reproduction are developed.
|
|
| domain | founded_year | HQ Location |
Developer of advanced sperm collection and processing technologies. It offers solutions for at-home semen analysis and in-clinic sperm processing, improving sperm quality and increasing the chances of successful conception. The company's products are designed to enhance sperm viability during collection, transport, and preparation for various fertility treatments, including IUI, IVF, and ICSI. These technologies aim to simplify the process for both patients and healthcare providers, improving outcomes and reducing stress. The company also provides support and resources for patients and clinics.
|
|
| domain | founded_year | HQ Location |
Develops innovative sperm separation devices for medical applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Memphasys
Frequently Asked Questions about Memphasys
When was Memphasys founded?
Memphasys was founded in 2006 and raised its 1st funding round 16 years after it was founded.
Where is Memphasys located?
Memphasys is headquartered in Homebush, Australia. It is registered at Homebush, New South Wales, Australia.
Who is the current CEO of Memphasys?
Alison Coutts is the current CEO of Memphasys.
What is the annual revenue of Memphasys?
Annual revenue of Memphasys is $2.44K as on Jun 30, 2025.
What does Memphasys do?
Memphasys was founded in 2006 and is based in Homebush, Australia. Operations center on biotechnology for reproductive health, where an automated electrophoretic system called the Felix device is developed. This system separates sperm from raw semen, supporting assisted reproductive technologies. The companys work addresses challenges in fertility treatments through innovative cell separation methods.
Who are the top competitors of Memphasys?
Memphasys's top competitors include Cytoswim, Reproductive Solutions and ZyMot.
What products or services does Memphasys offer?
Memphasys offers Felix™ System, Storage Medium, and Improved Medium.
Is Memphasys publicly traded?
Yes, Memphasys is publicly traded on ASX under the ticker symbol MEM.
Who are Memphasys's investors?
Memphasys has 1 investor. Key investors include Peters Investment Group.
What is Memphasys's ticker symbol?
The ticker symbol of Memphasys is MEM on ASX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.